Aquilo Capital Management as of March 31, 2019
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares NASDAQ Biotechnology Index (IBB) | 24.7 | $56M | 500k | 111.80 | |
| SPDR S&P Biotech (XBI) | 20.0 | $45M | 500k | 90.54 | |
| Merus N V (MRUS) | 9.8 | $22M | 1.5M | 14.77 | |
| Uniqure Nv (QURE) | 9.6 | $22M | 365k | 59.65 | |
| Arrowhead Pharmaceuticals (ARWR) | 8.0 | $18M | 983k | 18.35 | |
| Spero Therapeutics (SPRO) | 6.0 | $14M | 1.1M | 12.81 | |
| Fate Therapeutics (FATE) | 5.4 | $12M | 697k | 17.57 | |
| Synlogic | 4.7 | $11M | 1.4M | 7.59 | |
| Xenon Pharmaceuticals (XENE) | 4.3 | $9.7M | 952k | 10.16 | |
| Proqr Thrapeutics N V call | 3.0 | $6.8M | 487k | 13.87 | |
| Pieris Pharmaceuticals (PIRS) | 1.8 | $4.1M | 1.2M | 3.35 | |
| Galapagos Nv- (GLPG) | 1.1 | $2.6M | 22k | 117.77 | |
| Blueprint Medicines (BPMC) | 1.1 | $2.5M | 31k | 80.05 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $1.1M | 102k | 10.75 |
